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1. Introduction
Neoplasia of the stomach represents the second most recurrent cause of cancer mortality in
the world [1]. Despite major efforts, the number of deaths from gastric cancer has not de‐
creased in recent years. There have also been major efforts to better understand the mecha‐
nisms responsible for oncogenesis and a number of animal models of have been developed
to study the correlates of gastric carcinoma in recent years [2, 3]. Among these, the 1-meth‐
yl-3-nitro-1-nitrosoguanidine (MNNG) model has proven to be very useful. Evidences sug‐
gest that MNNG administration results in oncogenesis as a result of increased free radical
synthesis in the gastric mucosa [4, 5]. DNA damage induced by oxidative stress and/or defi‐
cient DNA-repair is reported to have an etiological or prognostic role in cancer [4].
Research also suggests that electrophiles could play a key role in chemical carcinogenesis.
The oxidative inactivation of enzymes by free radicals and accumulation of oxidized pro‐
teins may play a critical role in the alteration of cellular function and cell death. Oxidative
damage can generate large amounts of carbonyl products and hence measurement of these
components could reflect oxidative protein damage [6]. Synthesis of certain polyamines no‐
tably histamine, putrescine, spermine and spermidine is essential for the regulation of pro‐
tein, RNA and DNA synthesis. In addition, the ability of polyamines to alter DNA–protein
© 2013 Ganapathy et al.; licensee InTech. This is an open access article distributed under the terms of the
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interactions could disrupt certain cellular functions under cancerous conditions [7]. These
biomarkers are biological and molecular end-points that are quantitatively modulated by
chemopreventive agents and as such could indicate the efficacy of the dietary agents.
Dietary antioxidants are important health-protecting factor. Studies have convincingly stat‐
ed that frequent consumption of fruits and vegetables rich in antioxidants could decrease
the risk of cancer [8]. Naringenin, a flavanone compound highly enriched in grapefruits, has
been identified as a possible inhibitor of cell proliferation and potential to act as an antitu‐
morigenic agent [9-11]. We recently reported that naringenin could reduce tumor size, ROS
levels and enhance antioxidant status [12]. However, the mechanism of action of naringenin
to suppress cell growth is still ambiguous since this compound appears to have multiple cel‐
lular targets including cytochrome P450 enzymes [13]. We analyzed gastric cancer induced
by MNNG, which reportedly induce cellular oxidative damage through DNA strand breaks
[14] and explored the possible protective role of naringenin by measuring the levels of pro‐
tein damage and polyamine synthesis in MNNG-induced gastric carcinogenesis in experi‐
mental rats.
2. Materials and methods
2.1. Drugs and chemicals
MNNG, Naringenin [~95%, C15H12O5; (±)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxy phenyl)
-4H-1-benzopyran-4-one 4′,5,7-Trihydroxyflavanone, Molecular Weight: 272.25, CAS Num‐
ber 67604-48-2] Histopaque 1077, RPMI 1640 and BSA were purchased from Sigma (St.Louis,
MO, USA), Hanks Balanced Salt Solution from Himedia (Mumbai, India), LMPA and other
chemicals of analytical grade were purchased from SRL, Mumbai, India.
2.2. Animals
All the experiments were carried out with male Wistar rats 6–8 weeks old (80-90g) obtained
from the Central Animal House, University of Madras, Dr. ALM PG IBMS, Taramani, Chen‐
nai, Tamilnadu, India. The rats were housed six in a polypropylene cage and provided food
and water ad libitum. The animals were maintained under standard conditions of tempera‐
ture (23 ± 2ºC) and humidity (50-70%) with an alternating 12-hour light/dark cycle with free
access to standard pellet diet (Mysore Snack Feed Ltd, Mysore, India) and maintained in ac‐
cordance with the guidelines of the National Institute of Nutrition, Indian Council of Medi‐
cal Research (ICMR), Hyderabad, India and approved by the ethical committee of
University of Madras (IAEC no. 02/055/05).
2.3. Treatment schedule
Rats in Group I served as control and was given oral corn oil for 20 weeks. Group II animals
were induced with MNNG 200 mg/kg b. wt, by oral gavage at days 0 and 14 and saturated
NaCl (1ml/rat) was given 3 days once for four weeks and maintained till the end of the ex‐
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perimental period. Group III animals were induced with MNNG + NaCl (as in group II) and
treated with naringenin (200 mg/kg b.wt, dissolved in corn oil, orally) simultaneously for 20
weeks from the first dose of MNNG + NaCl. Group IV animals were post-treated with narin‐
genin (200 mg/kg b.wt, dissolved in corn oil, orally) from the 6th week of MNNG (as in
group II) induction up to end of experimental period. Group V animals were treated with
naringenin (200 mg/kg b.wt, dissolved in corn oil, orally) alone for 20 weeks. The experi‐
ment was terminated at the end of 20 weeks and all the animals were sacrificed by cervical
dislocation after an overnight fasting.
2.4. Tumour weight
Tumour weight was estimated according to the method of Geren et al.,[15]. The resultant
solid tumour was considered to be prelate ellipsoid with one long axis and two short axes.
The two short axes were measured using a vernier caliper. The tumour weight was calculat‐
ed by multiplying the length of the tumour with the square of the width and dividing the
product by 2.
2.5. Analysis of ROS
To examine the in vivo generation of ROS, we used the cell permeable probe 2’, 7’-dichloro‐
dihydrofluorescin diacetate (CM-H2DCFH-DA; Molecular Probes, Eugene, OR, USA) ac‐
cording to the method described by Parsons et al.,[16]
2.6. Biochemical analysis
The oxidative protein damage was determined by the estimation of carbonyl content by the
method of Levins et al., [17]. Protein content was estimated by the method of Lowry et al.,
[18]. The DNA and RNA contents were estimated in the homogenate by the method of Bur‐
ton [19] and Rawal et al., [20]. Lipid peroxidation (LPO) was estimated by the method of
Ohkawa et al., [21].
2.7. DNA fragementation
The extent of DNA fragmentation was measured by the method of Sellins and Cohen [22].
The isolated DNA was visualized for fragmentation by electrophoresis in a 1.2% agarose gel
containing ethidium bromide.
2.8. Assessment of DNA damage
DNA damage was assessed with alkaline single cell gel electrophoresis (comet assay) ac‐
cording to the method described by Singh et al., [23].
2.9. Polyamine analysis
Separation of various polyamine fractions such as histamine, putrescine, spermine and sper‐
midine and their subsequent estimation was done by the method of Endo [24]. CM-cellulose
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column chromatography: Rat tissues (stomach-100 mg) were homogenized in ice-cold 0.4 M
HClO4 containing 2 mM ethylenediaminetetracetic acid. The homogenate was centrifuged at
1000 g for 5 min. The neutralized supernatant was applied to a CM cellulose column. Each
sample solution (0.5 – 3 mL) was applied to a CM-cellulose column (0.6×10 cm) equilibrated
with 0.01 M phosphate buffer (pH 6.2). After the column was washed with 15 mL of 0.01 M
phosphate buffer (pH 6.2) and 15 mL of 0.03 M phosphate buffer (pH 6.2), histamine, putres‐
cine, spermidine and spermine were eluted out from the column with borate buffer without
NaCl (30 mL), borate buffer containing 0.03 M NaCl (20 mL), borate buffer containing 0.075
M NaCl (20 mL), and borate buffer containing 0.15 M NaCl (20 mL), respectively. Fractions
(3 mL) were collected at a flow rate of approximately 3 mL/min. Trinitrobenzenesulphonate
(TNBS) reagent (1 mL) was added to the elute (3 mL) from the CM-cellulose column. The
reaction was carried out at 50°C for 10 min and terminated by cooling the reaction mixture
in water. Absorbance at 420 nm was measured within 20 min.
2.10. Statistical analysis
The data are presented as mean ± SD for six rats in each group. Significance of the differen‐
ces between mean values was determined by one-way analysis of variance (ANOVA) fol‐
lowed by the Duncan test for multiple comparison. P values 0.001, 0.01, 0.05 were
considered to reveal significance.
3. Results
The mean body weights were decreased and tumor weights increased in group II (MNNG +
S-NaCl) animals as compared with all the other groups (Table 1). A 100% incidence in gas‐
tric cancer was noticed among group II animals. Importantly, naringenin treatment signifi‐
cantly increased the body weight and decreased the tumor weights among group III (p<0.05)
and IV animals as compared to group II animals. Furthermore, a progressive increase in the
mean body weight was observed among group V animals during the experimental period.
Conceptually, the increase in body weight after the administration of naringenin in Group
III and Group IV rats highlights the protective efficacy of the flavonoid.
A significant increase in ROS generation was observed in stomach and liver tissue of
MNNG induced groups II animals as compared with control animal group I (Fig. 1). How‐
ever, there was significantly decreased activity in group III and group IV naringenin treated
animals. The results were suggested that the antioxidant effect of naringenin in MNNG in‐
duced animals could be due to its free radical scavenging action.
Figure 2a and 2b shows the levels of LPO and protein carbonyl content in stomach and liver
tissues of various experimental groups. A significant (p<0.001) increase in the extent of LPO
and protein carbonyl content was observed in the stomach and liver of carcinoma bearing
group II animals as compared to the control animals (group I). Naringenin significantly de‐
creased the LPO and protein carbonyls of group III and group IV animals (p<0.001, p<0.01)
as compared to carcinogen-induced group II rats. However, naringenin alone treated ani‐
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mals (group V) did not show any significant change as compared with the control animals
(group I).
Groups Group I (Control) Group II (MNNG +NaCl Induced)
Group III
(Naringenin
simultaneous
treatment)
Group IV
(Naringenin post
treatment)
Group V
(Naringenin
alone)
Body Weight (g) 310.17 ± 15.78 166.41± 16.80a# 270.18 ± 17.99b@ 230.75 ±15.18b@c@ 330.23 ± 16.08
Tumor weight (g) - 0.72 ± 0.05 0.31±0.03 a# 0.51±0.04a@ b# -
No. of rats with
gastric cancer (%) 0 (0%) 6/6 (100%) 0/6 (0%) 2 (33.3%) 0 (%)
Values are expressed as mean ± SD (n=6) for each group. Different letters represent significant variations as calculated
by 1-way analysis of variance and the Duncan test. Body weight: a, as compared with group I; b, as compared with
group II; c, as compared with group III. Tumor weight: a, as compared with group II. @ - p<0.05; # - p<0.01; * - p<0.001.
Table 1. Effect of naringenin on body and tumor weight and incidence of gastric cancer of control and experimental
rats.
Figure 1. Effect of naringenin on ROS generation in control and experimental animals. ROS production estimated by
oxidation of the fluorescent probe, DCFDA. Groups (I-V) are Control, MNNG induced, naringenin simultaneous treat‐
ment, naringenin post treated and naringenin alone respectively. The details are described under materials and meth‐
ods. Values are the mean ± SD of six rats in each group. (a-c) represent (a) as compared with Group I; (b) as compared
with Group II; (c) as compared with group III (*p<0.001,@p<0.01, #p<0.05).
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Figure 2. a. Effect of naringenin on lipidperoxidation in stomach and liver of control and experimental animals. For‐
mation of lipid peroxidation product was determined in terms of MDA as described under materials and methods.
Groups (I-V) are Control, MNNG induced, naringenin simultaneous treatment, naringenin post treated and naringenin
alone respectively. Units: nmoles of MDA release/mg protein. Values are the mean ± SD of six rats in each group. (a-c)
represent (a) as compared with Group I; (b) as compared with Group II; (c) as compared with group III
(*p<0.001,@p<0.01, #p<0.05). b. Effect of naringenin on protein carbonyl formation in control and experimental ani‐
mals. Oxidation of Stomach and liver proteins of all animals were determined in terms of protein carbonyl formation.
Groups (I-V) are Control, MNNG induced, naringenin simultaneous treatment, naringenin post treated and naringenin
alone respectively. The details are described under materials and methods. Units: nmoles/mg protein. Values are the
mean ± SD of six rats in each group. (a-c) represent (a) as compared with Group I; (b) as compared with Group II; (c) as
compared with group III (*p<0.001,@p<0.01, #p<0.05).
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Fig. 3 shows the agarose gel electrophoretic pattern of DNA isolated from the stomach tissue
of control and experimental animals. In group I control and group II cancer bearing animals,
there was no significant DNA fragmentation. Naringenin treated (group III) animals exhibit‐
ed a significant DNA fragmentation. In group IV animals was shown less DNA fragmenta‐
tion when compared with group III. However, a significant fragmentation of DNA was
observed in animals treated with naringenin alone (group V).
Figure 3. Effect of naringenin on DNA fragmentation in control and experimental animals. Groups (I-VI) are Control,
MNNG induced, naringenin simultaneous treatment, naringenin post treated, naringenin alone and DNA marker re‐
spectively. The details are described under materials and methods. DNA was isolated by agarose gel electrophoresis
and visualized by ethidium bromide staining.
Fig. 4 shows the level of DNA damage measured using single cell gel electrophoresis in
stomach tissue of control and experimental animals. There was a significant increase in
DNA tail length (3.21- fold) in cancer bearing animals (group II) as compared with group I
control animals and significant decrease (2.27 - fold) in Group III and Group IV in (1.84-fold)
(naringenin treated) animals when compared with group II animals. In addition, there was
no comparable difference between rats treated with naringenin alone (group V) and the con‐
trol animals.
Figure 5 and 6 shows the levels of nucleic acids and polyamines in the stomach of control
and experimental animals. Cancer induced animals (group II) showed a significant increase
(p<0.001) in nucleic acid and polyamine contents in stomach tissue when compared with the
control animals (group I). On treatment with naringenin (group III and group IV), there was
found to be a significant (p<0.001, p<0.01) decrease in the levels of nucleic acids and polya‐
mines in stomach tissue when compared with cancer-induced animals (group II). However,
naringenin alone treated animals (group V) did not show any significant changes when
compared with control animals (group I).
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Figure 4. Effect of naringenin on DNA single strand breaks in control experimental animals. Oxidative DNA damage in
stomach of control and experimental animals were determined by comet assay. Groups (I-V) are Control, MNNG in‐
duced, naringenin simultaneous treatment, naringenin post treated and naringenin alone respectively. The details are
described under materials and methods. DNA tail length was expressed in µm. Values are the mean ± SD of six rats in
each group. (a-c) represent (a) as compared with Group I; (b) as compared with Group II; (c) as compared with group
III (*p<0.001,@p<0.01, #p<0.05).
Figure 5. Effect of naringenin on the levels of nucleic acid content in stomach of control and experimental animals.
Groups (I-V) are Control, MNNG induced, naringenin simultaneous treatment, naringenin post treated and naringenin
alone respectively. The details are described under materials and methods. Units: mg/g wet tissue. Values are the
mean ± SD of six rats in each group. (a-c) represent (a) as compared with Group I; (b) as compared with Group II; (c) as
compared with group III (*p<0.001,@p<0.01, #p<0.05).
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Figure 6. Effect of naringenin on the levels of polyamines in stomach of control and experimental animals. 25 frac‐
tions were collected from each group. Groups (I-V) are Control, MNNG induced, naringenin simultaneous treatment,
naringenin post treated and naringenin alone respectively. The details are described under materials and methods.
4. Discussion
Development of a diet that provides adequate nutrition and effective cancer prevention is an
important goal in nutrition and cancer research [8]. We suggest that naringenin could be an
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effective chemopreventive agent in MNNG induced gastric carcinoma. ROS and organic free
radical intermediates formed from carcinogens reportedly initiate carcinogenic transforma‐
tion [25]. Consequently, the accumulation of free radical mediated damage may be a possi‐
ble mechanism of cancer development [26]. MNNG is an effective carcinogen with a
capability to induce enormous amounts of free radicals, which in turn reacts with lipids
causing release of lipid peroxides [27]. Naringenin significantly reduced the lipid peroxides
and increased free radicals scavenging capabilities in cancer bearing animals, which could
be due to its capability to enhance antioxidant enzymes [28,29]. This has been supported by
our recent report that administration of naringenin to gastric carcinoma-induced rats largely
upregulated the redox status to decrease the risk of cancer [12]. The antioxidant enzymes
may reduce the carcinogen-DNA interaction by providing a large nucleophilic pool for the
electrophilic carcinogens such as MNNG [30], and it causes oxidative protein damage in
gastric carcinogenesis-induced animals [31]. Among the various oxidative modifications in
protein, carbonyl formation may be an early marker for protein oxidation [32]. Protein car‐
bonyls have been used as a biomarker of oxidative stress because of the relative stability of
carbonylated proteins and the high protein concentration in blood. However, we found that
tissue carbonyl levels in naringenin treated groups were decreased when compared with
MNNG induced with cancer.
A number of flavonoids have been shown to suppress carcinogenesis in various animal
models [33]. There is currently considerable interest in these compounds as they appear to
exert a beneficial effect on several key mechanisms involved in the pathogenesis of cancer.
DNA fragmentation is generally considered to be the hallmark of apoptosis. Indeed the nu‐
clear DNA of apoptotic cells shows a characteristic laddering pattern of oligonucleosomal
fragments. Several studies have demonstrated a positive correlation between DNA fragmen‐
tation and apoptosis. Medicinal plants and natural dietary constituents such as naringenin
have been reported to induce apoptosis in malignant cells in vitro [34]. Our present study we
observed DNA fragmentation induced by naringenin, which possess, prevention of MNNG.
Additionally, we have also observed an induction of apoptosis on naringenin in stomach
cancer bearing animals as revealed by the enhancement of LPO and oxidative DNA damage.
The absence of intranucleosomal DNA-fragmentation in MNNG induced animals reflects
the prevention of apoptotic mechanisms in malignant cells. Our report has shown that intra‐
nucleosomal DNA fragmentation during chemoprevention of naringenin treated rats. The
results support that the findings of key changes in cell death can occur without DNA frag‐
mentation and it alone should not be considered as a criterion for assessing apoptotic cell
death [35].
Feng et al.,  [36] reported natural antioxidants are capable of inhibiting the ROS produc‐
tion and thereby reducing the associated intra-cellular oxidative stress. Importantly, ROS,
damaging almost all classes of subcellular components, are produced in numerous patho‐
physiological states and have been recognized as participating in the development of mul‐
tistage carcinogenesis [37]. Oxidative stress is associated with damage to a wide range of
macromolecular  species  including  lipids,  proteins,  and  nucleic  acids  thereby  producing
major interrelated derangements of  cellular metabolism including peroxidation of  lipids,
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formation  of  protein  carbonyls,  and  single  strand  breaks  in  DNA  [38].  Previous  report
from our laboratory, dietary agent could effectively inhibited B(a)P induced lung carcino‐
genesis by offering protection from protein damage and also by suppressing cell prolifer‐
ation  [39].  Our  result  demonstrated  that  naringenin;  MNNG  induced  intracellular  ROS
and oxidized protein carbonyl  accumulation dependent on the hydroxyl  group presents
in the structure [40,41].
LPO is the most studied biologically relevant free radical chain reaction. It is regarded as
one of the basic mechanisms of tissue damage caused by free radicals [42]. Increased level of
LPO was reported during DEN induced and Phenobarbital promoted hepatocellular carci‐
nogenesis [26]. In this result, an increased level of tail length was observed in carcinogen in‐
duced rats (Group II). The OH- radical is implicated to the oxidation of DNA bases, the most
studied, product being 8-oxo-7, 8-dihydroguanine. Oxygen radicals attack DNA bases and
deoxyribose residues producing damaged bases and single stand breaks. This radical in‐
duced oxidative stress generated a large number of modifications in DNA including strand
breaks [36]. Contrary to this, the diets rich in fruits and vegetables can decrease both DNA
damage and cancer incidence [43].
Polyamines are essential for the growth of cells and rapidly proliferating cells have higher
levels of polyamines than do slowly growing or quiescent cells [44]. Earlier studies with dif‐
ferent carcinoma tissues have demonstrated a marked increase in the levels of polyamines
and ornithine decarboxylase (ODC) activity, confirming their correlation with neoplastic
growth and high rate of cell proliferation [45]. Others cited the importance of polyamines in
chemotherapy by demonstrating depleted levels of polyamines upon treatment with anti‐
cancer agents [39, 46]. Earlier reports demonstrate the potential of flavonoids and alkaloids
to inhibit ODC in various cancer conditions [47]. Hence, naringenin, one of the flavonoids,
may inhibit ODC activity and reduce cell proliferation in stomach carcinogenesis through
depleting the levels of polyamines.
One or more independent/interdependent pathways such as the inhibition of activation of
MNNG to the ultimate carcinogen, it’s antioxidative and free radical scavenging properties
may be responsible for the anticancer potential of naringenin [48]. Our study strongly dis‐
plays the protective effect of naringenin against MNNG induced gastric carcinogenesis,
which may be due to its inhibitory effect on cell proliferation. Therefore, naringenin may be
explored as a chemopreventive agent for humans at high risk of gastric cancer.
Acknowledgments
Ganapathy. Ekambaram gratefully acknowledges the Indian Council of Medical Research
(ICMR), Ministry of Human Resources and Manpower Development, Government of India,
New Delhi, India for the financial assistance awarded in the form of a senior research fel‐
lowship (Grant No: 3/2/2/96/2006/NCD-III; dt 20/9/06).
Naringenin and Gastric Carcinogenesis
http://dx.doi.org/10.5772/45896
121
Author details
Ekambaram Ganapathy1, Devaraja Rajasekaran2, Murugan Sivalingam2,
Muhammed Farooq Shukkur3, Ebrahim Abdul Shukkur4 and Sakthisekaran Dhanapal2*
*Address all correspondence to: g_ekambaram@yahoo.co.in
1 Department of Pathology and Lab Medicine, David Geffen School of Medicine, University
of California, Los Angeles, California, USA
2 Department of Medical Biochemistry, Dr. ALM PG Institute of Basic Medical Sciences,
University of Madras, Taramani Campus, Chenna, India
3 Internal Medicine, Wayne State University, School of Medicine, Detroit, Michigan, USA
4 Pharmacy Practice, Wayne State University, Detroit, Michigan, USA
References
[1] Chen, J., Rocken, C., Malfertheiner, P. and Ebert, M.P. (2004) Recent advances in mo‐
lecular diagnosis and therapy of gastric cancer. Dig. Dis, 22, 380 – 5.
[2] Su, Y.P., Tang, J.M., Tang, Y. and Gao, H.Y. (2005) Histological and ultrastructural
changes induced by selenium in early experimental gastric carcinogenesis. World J
Gastroenterol, 11, 4457-60.
[3] Kodama, M., Murakami, K., Sato, R., Okimoto, T., Nishizono, A. and Fujioka, T.
(2005) Helicobacter pylori-infected animal models are extremely suitable for the in‐
vestigation of gastric carcinogenesis. World J Gastroenterol, 11: 7063-71.
[4] Lin, C.T., Lin, W.H., Lee, K.D. and Tzeng, P.Y. (2006) DNA mismatch repair as an ef‐
fector for promoting phorbol ester-induced apoptotic DNA damage and cell killing:
implications in tumor promotion. Int. J. Cancer, 119, 1776-84.
[5] Fiaschi, A.I., Cozzolino, A., Ruggiero, G. and Giorgi, G. (2005) Glutathione, ascorbic
acid and antioxidant enzymes in the tumor tissue and blood of patients with oral
squamous cell carcinoma. Eur. Rev. Med. Pharmacol Sci. 9, 361-7.
[6] Sundari, P.N., Wilfred, G.J. and Ramakrishna, B. (1997) Oxidative protein damage
plays a role in pathogenesis of carbon tetrachloride induced liver injury in the rat.
Biochim. Biophys. Acta, 1362, 169 – 76.
[7] Thomas, T. and Thomas, T.J. (2001) Polyamines in cell growth and cell death: molec‐
ular mechanisms and therapeutic applications. Cell Mol. Life Sci, 58, 244 – 58.
[8] Sauer, L.A., Blask, D.E. and Dauchy, R.T. (2007) Dietary factors and growth and me‐
tabolism in experimental tumors. J. Nutr. Biochem. 18, 637-49.
Gastric Carcinoma- New Insights into Current Management122
[9] Moon, Y.J., Wang, X. and Morris, M.E. (2006) Dietary flavonoids: effects on xenobiot‐
ic and carcinogen metabolism. Toxicol In Vitro 20, 187 - 210.
[10] Russ, M., Martinez, R., Ali, H. and Steimle, P.A. (2006) Naringenin is a novel inhibi‐
tor of Dictyostelium cell proliferation and cell migration. Biochem. and Biophy. Res.
Commun. 345, 516 – 22.
[11] Silberberg, M., Gil-Izquierdo, A., Combaret, L., Remesy, C., Scalbert, A. and Morand,
C. (2006) Flavanone metabolism in healthy and tumor-bearing rats. Biomed Pharmac‐
other. 60, 529 - 35.
[12] Ekambaram, G., Rajendran, P., Magesh, V. and Sakthisekaran. (2008) Antioxidant
and free radical scavenging effect of naringenin reduces tumor size and weight loss
in N-Methyl-N'-Nitro-N-Nitrosoguanidine induced gastric carcinogenesis. Nutr. Res.,
28; 106-112
[13] Ross, J.A. and Kasum, C.M. (2002) Dietary flavonoids: bioavailability, metabolic ef‐
fects, and safety. Annu. Rev. Nutr. 22, 19 – 34.
[14] Oshima, H., Yoshie, Y., Auriol, S. and Gilibert, I. (1998) Antioxidant and pro-oxidant
actions of flavonoids: effects on DNA damage induced by nitric oxide, peroxynitrite
and nitroxyl anion. Free Radical Biol. Med. 25, 1057 – 65.
[15] Geren, R.J., Greenberg, N.H., Mcdonald, M.M. and Schumacher, A.M. (1972) Proto‐
cols for screening chemical agents and natural products against animal tumours and
other biological systems. Cancer Chemotherapy Report. 3, 1-103.
[16] Parsons, H.L., Yip, J.Y.H. and Vanlerberge, G.C. (1999) Increased respiratory restric‐
tion during phosphate-limited growth in transgenic tobacco cells lacking alternative
oxidase. Plant Physiol. 121, 1309 – 20.
[17] Levins, R.L., Garland, D., Oliver, C.N., et al. (1990) Determination of carbonyl con‐
tents in oxidative modified proteins. Methods Enzymol, 186, 464 – 78.
[18] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measure‐
ment with the Folin phenol reagent. J. Biol. Chem. 193, 265 – 75.
[19] Burton, K. (1956) A study of the conditions and mechanism of the diphenylamine re‐
action for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62, 315 -
23.
[20] Rawal, V.M., Patel, V.S., Rao, G.N. and Desai G.R. (1977) Chemical and biochemical
studies on characters of human lenses: III. Quantitative study of protein, RNA and
DNA. Arogya J Health Sci 3, 315 - 9.
[21] Ohkawa, H., Ohishi, N. and Yagi, K.Y. (1979) Assay of lipid peroxides in animal tis‐
sues by thiobarbituric acid reaction. Anal. Biochem, 95, 351–8.
[22] Sellins, K.S. and Cohen, J.J. (1987) Gene induction by γ-irradiation leads to DNA
fragmentation in lymphocytes. J. Immunol. 139, 3199 - 3206.
Naringenin and Gastric Carcinogenesis
http://dx.doi.org/10.5772/45896
123
[23] Singh, J. and Roscher, E. (1991) Induction of DNA damage by N-nitrosodiethylamine
in rat hepatoma cells: correlation with cytochrome P450-mediated aldrin epoxidase
activity. Mutagenesis. 6, 117 - 21.
[24] Endo, Y. (1978) A simple and sensitive method of analysis of histamine, putrescine
and polyamines without the use of an amino acid analyser. Anal. Biochem. 89, 235 –
46.
[25] Panandiker, A., Maru, G.B. and Rao, K.V.K. (1994) Dose response effects of malachite
green on free radical formation, lipid peroxidation and DNA damage in hamster em‐
bryo cells and their modulation by antioxidants. Carcinogenesis. 15, 2445 – 8.
[26] Thirunavukkarasu, C. and Sakthisekaran, D. (2001) Effect of selenium on N-nitroso‐
diethylamine induced multistage hepatocarcinogenesis with reference to lipid perox‐
idation and enzymic antioxidants. Cell Biochem. Funct. 19, 27 - 35.
[27] Tandon, R., Khanna, H.D., Dorababu, M. and Goel, R.K. (2004) Oxidative stress and
antioxidants status in peptic ulcer and gastric carcinoma. Indian J. Physiol. Pharmacol.
48, 115 - 8.
[28] Mildred, K., Richerd, L., Joseph, G., Alexander, W. and Conney, A. (1981) Activation
and inhibition of benzo(a)pyrene and aflatoxinB1 metabolism in human liver micro‐
somes by naturally accruing flavonoids. Cancer Res. 41, 67 – 72.
[29] Yao, H., Liao, Z.X., Wu, Q., Lei, G.Q., Liu, Z.J., Chen. D.F., Chen, J.K. and Zhou, T.S.
(2006) Antioxidative flavanone glycosides from the branches and leaves of Viscum
coloratum. Chem. Pharm. Bull. 54, 133 - 5.
[30] Wyatt, M.D. and Pittman, D.L. (2006) Methylating agents and DNA repair responses:
Methylated bases and sources of strand breaks. Chem. Res. Toxicol. 19, 1580 - 94.
[31] Izzotti, A., De Flora, S., Cartiglia, C., Are, B.M., Longobardi, M., Camoirano, A.,
Mura, I., Dore, M.P., Scanu, A.M., Rocca, P.C., Maida, A. and Piana, A. (2007) Inter‐
play between Helicobacter pylori and host gene polymorphisms in inducing oxida‐
tive DNA damage in the gastric mucosa. Carcinogenesis, 28, 892 - 8.
[32] Liggins, J. and Furth, A.J. (1997) Role of protein carbonyl groups in the formation of
advanced glycation end products. Biochim. Biophys. Acta, 1361, 123 – 30.
[33] Yang, C.S., Landau, J.M., Huang, M.T. and Newmark, H.L. (2001) Inhibition of Carci‐
nogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 21, 381 – 406.
[34] Traphdar, A.K., ROY, M. and Bhattacharya, R.K. (2001) Natural products as inducers
of apoptosis: implication for cancer therapy and prevention. Curr. Science, 80, 1387 -
95.
[35] Cohn, S.M., Sun, X.M., Snowden, R.T., Dinsdale, D. and Skillter, D.N. (1992) Morpho‐
logical features of apoptosis may occur in the absences of micronucleosomal DNA
fragmentation. Biochem. J, 286, 331 - 4.
Gastric Carcinoma- New Insights into Current Management124
[36] Feng, Q., Kumagai, T., Torii, Y., Nakamura, Y., Osawa, T. and Uchida, K. (2001) Anti‐
carcinogenic antioxidants as inhibitors against intracellular oxidative stress. Free Rad‐
ic Res, 35, 779 – 88.
[37] Jeyabal, P.V., Syed, M.B., Venkataraman, M., Sambandham, J.K. and Sakthisekaran,
D. (2005) Apigenin inhibits oxidative stress-induced macromolecular damage in N-
nitrosodiethylamine (NDEA)-induced hepatocellular carcinogenesis in Wistar albino
rats. Mol. Carcino, 44, 11 - 20.
[38] Young, I.S. and Woodside, J.V. (2001) Antioxidants in health and disease. J. Clin.
Pathol, 154, 176 - 86.
[39] Selvendiran, K., Mumtaz Banu, S. and Sakthisekaran, D. (2004) Protective effect of pi‐
perine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Clinica
Chimica Acta, 350, 73-78.
[40] Miyoshi, N., Naniwa, K., Yamada, T., Osawa, T. and Nakamura, Y. (2007) Dietary fla‐
vonoid apigenin is a potential inducer of intracellular oxidative stress: The role in the
interruptive apoptotic signal. Arch. Biochem. Biophys, 466, 274 – 82.
[41] Rice-Evans, C. (2004) Flavonoids and isoflavones: absorption, metabolism, and bioac‐
tivity. Free Radic. Biol. Med, 36, 827–828.
[42] Esterbauer, H., Schaur, R.J. and Zollner, H. (1991) Chemistry and biochemistry of 4-
hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med, 11, 81 -
128.
[43] Welch, R.W., Turley, E., Sweetman, S.F., Kennedy, G., Collins, A.R., Dunne, A., Liv‐
ingstone, M.B., McKenna, P.G., McKelvey-Martin, V.J. and Strain, J.J. (1999) Dietary
antioxidant supplementation and DNA damage in smokers and nonsmokers. Nutr.
Cancer, 34, 167 - 72.
[44] Milovica, V., Turchanowa, L., Khomutov, R.M., Caspary, W.F. and Stein, J. (2001)
Hydroxylamine-containing inhibitors of polyamine biosynthesis and important of
colon cancer cell growth. Biochem. Pharmacol. 61, 199 – 206.
[45] Farriol, M., Segovia, S.T., Venero, Y. and Orta, X. (2001) Role of polyamines in cell
proliferation in a colon carcinoma cell line. Nutrition, 17, 934 – 8.
[46] Pegg, A. (1988) Polyamine metabolism and its importance in neoplastic growth and
as a target for chemotherapy. Cancer Res, 48, 759 – 74.
[47] Edurdo, D.S., Paolo, B. and Hugo, D. (1999) Dietary antioxidants and lung cancer
risk. Nutr. Cancer. 34, 100 – 10.
[48] Kuo, S.M. (1996) Antiproliferative potency of structurally distinct dietary flavonoids
on human colon cancer cells. Cancer Lett. 110, 41 – 8.
Naringenin and Gastric Carcinogenesis
http://dx.doi.org/10.5772/45896
125

